Léčba anemie pomocí erytropoetinu u pacientů s mnohočetným myelomem

Title in English Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma
Authors

ADAM Zdeněk KRAHULOVÁ M. ŠPELDA S. VORLÍČEK Jiří HEJLOVÁ N. HÁJEK Roman TOMÍŠKA Miroslav

Year of publication 1995
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords multiple myeloma; anemia; erythropoietin
Description Multiple myeloma is very frequently associated with anaemia which has the character of hypo-proliferative anaemia of chronic diseases. In this type of anaemia the erythropoietin formation is frequently inadequate. According to data in the literature pharmacological doses of erythropoietin lead to an increase of the haemoglobin concentration in blood. Erythropoietin (Eprex Cilag) was administered to 11 patients whose haemoglobin concentration was lower than 100 g/l.

You are running an old browser version. We recommend updating your browser to its latest version.

More info